Myobloc Atrophy Study "MAS"

Completed

Phase 4 Results N/A

Summary of Purpose

The present pilot study is designed to assess the extent to which BOTOX and MYOBLOC cause muscle atrophy in spastic patients. The primary objective is to assess whether there is statistically significant difference in muscle atrophy between the two groups over a one year period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 December 2015.

1 May 2014 29 Jan 2014 1 Aug 2015 1 Aug 2015 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts